This week's research roundup features: PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM.
Mayo Clinic Laboratories has validated the Centers for Disease Control and Prevention's test kit for monkeypox and will begin to ramp up testing.
As a two-time brain tumor survivor, Alex Kraatz has been through more harrowing medical experiences in his 34 years than most people face in a lifetime. But Alex’s fighting spirit, coupled with precision laboratory testing and cutting-edge treatments, have propelled him forward, keeping him hopeful despite the odds.
As manager of the department’s Education Program, Deb Hagen-Moe and her team welcome new staff to Mayo Clinic’s Department of Laboratory Medicine and Pathology. Then they continue to offer a wide range of continuing education and professional development to those staff members throughout their careers.
This week’s research roundup features: The publication impact of the first 100 THOR Network publications by bibliometric and social network analyses.
This week’s research roundup features: Understanding "Patient refuses" among 90+ year old patients with cancer or presumed cancer.
Partnering with Mayo Clinic has helped St. Clair Health improve patient care and gain a new competitive advantage in pharmacogenetics.
Featured Abstract: A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.
Guided by a patient-centric philosophy, Mayo Clinic Laboratories has a unique internal structure of quality specialists, coordinators, and engineers who constantly evaluate and improve laboratory operations. This structure supports a host of quality assurance activities.
As director of Regulatory Affairs for the Department of Laboratory Medicine and Pathology, Shannon Bennett helps safeguard Mayo Clinic’s reputation for quality care by ensuring that its clinical laboratories operate at the highest level of regulatory compliance.
Featured Abstract: Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities.
This unique Mayo Clinic resource offers a novel portal into the study of gene mutations before they cause breast cancer.
Featured abstract: Nuclear GSK-3β and oncogenic KRas lead to the retention of pancreatic ductal progenitor cells phenotypically similar to those seen in IPMN.